Page last updated: 2024-09-05

sb 203580 and prostaglandin h2

sb 203580 has been researched along with prostaglandin h2 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(prostaglandin h2)
Trials
(prostaglandin h2)
Recent Studies (post-2010) (prostaglandin h2)
3,48941,137413034

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Börsch-Haubold, AG; Pasquet, S; Watson, SP1

Other Studies

1 other study(ies) available for sb 203580 and prostaglandin h2

ArticleYear
Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase.
    The Journal of biological chemistry, 1998, Oct-30, Volume: 273, Issue:44

    Topics: Arachidonic Acid; Calcium-Calmodulin-Dependent Protein Kinases; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Flavonoids; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Membrane Proteins; Platelet Activation; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Pyridines; Thromboxane A2; Thromboxane-A Synthase

1998